استکتی، گیل؛ فوآ، آدنا و گریسون، جاناتان. (1985). وسواس: برداشتها و درمان رفتاری، ترجمه امیرهوشنگ مهریار (1373). تهران: رشد.
کاپلان، اچ و سادوک، ب. (2002). خلاصه روانپزشکی-علوم رفتاری، روانپزشکی بالینی. جلد دوم. (ویراست نهم). ترجمه حسن رفیعی و خسرو سبحانیان (1383). تهران: انتشارات ارجمند.
Abramowitz, J. S. (1996). Variants of exposure and response prevention in the treatment of obsessive-compulsive disorder: A meta-analysis. Behavior Therapy, 27, 583-600.
Abramowitz, J. S. (1997). Effectiveness of psychological and pharmacological treatments for obsessive compulsive disorder: A quantitative review. Journal of Consulting and Clinical Psychology, 65, 44–52.
Abramowitz, J. S. (1998). Does cognitive-behavioral therapy cure obsessive–compulsive disorder? A meta-analytic evaluation of clinical significance. Behavior Therapy, 29, 339−355.
Abramowitz, J. S. Franklin, M. E. & Foa, E. B. (2002). Empirical status of cognitive-behavioral therapy for obsessive–compulsive disorder: A meta-analytic review. Romanian Journal of Cognitive and Behavioral Psychotherapies, 2, 89−104.
Abramowitz, J. S. Franklin, M. E. Zoellner, L. A. & DiBernardo, C. L. (2002). Treatment compliance and outcome of cognitive-behavioral therapy for obsessive-compulsive disorder. Behavior Modification, 26, 447-463
Abramowitz JS, Whiteside SP, Deacon BJ.)2005). The effectiveness of treatment for pediatric obses disorder: A meta-analysis.36:55–63.
Ball, S. G. Baer, L. & Otto, M. W. (1996). Symptom subtypes of obsessive–compulsive disorder in behavioral treatment studies: A quantitative review. Behaviour Research and Therapy, 34, 47−51.
Clark, D.A. & O, Connor, K. (2005). Thinking is believing: Ego dystonic intrusive thoughts in OCD. In D.A. Clark(Ed), Intrusive Thoughts in Clinical Disorders (pp.145-175). New York: Guilford Press.
Corey, G. (2007). Theory And Practice of Group Counceling.NEW YORC: Brooks Cole.
Cox, B. J. Swenson, R. P. Morrison, B. & Lee, P. S. (1993). Clomipramine, fluoxetine, and behavior therapy in the treatment of obsessive–compulsive disorder: A meta-analysis. Journal of Behavior Therapy and Experimental Psychiatry, 24, 149−153.
Eddy, K. T. Dutra, L. Bradley, R. &Westen, D. (2004). A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive–compulsive disorder. Clinical Psychology Review, 24, 1011−1030.
Emmelkamp, P. M. & Beens, H. (1991). Cognitive therapy with obsessive–compulsive disorder: A comparative evaluation. Behavior Research and Therapy, 29, 293−300.
Fienberg, N.A. Bullock, T. Montgomery, D.B.& Montgomery, S.A.)1992). Serotonin reuptake inhibitors are the treatment choice in obsessive compulsive disorder. Int Clin Psychopharmacol. 7:43-7
Fienberg, N. a. Gale, T.M. (2005). Evidence-based pharmacotherapy of obsessive-compulsive disorder. International Journal of Neuropsychopharmacology, 8:107-129. 168
Foa, E. B. Steketee,G. and Ozarow, B. J. (1985). Behavior therapy with obsessive-compulsives: From theory to treatment. In M. Mavissakalan, S.M. Turner, and L. Michelson (Eds.) Obsessive-compulsive disorder: Psychological and pharmacological treatments. (pp. 49-120). New York: Plenum Press.
Freeston, M. & Ladouceur, R. (1998). The cognitive-behavioral treatment of obsessions. In V. Caballo (Ed.), International handbook of cognitive and behavioural treatments for psychological disorders (pp. 129–160). Oxford, England7 Pergamon/ Elsevier.
Goodman, W. K. Price, L. H. & Rasmussen, S.A. et al. (1989). Efficacy of fluvoxamine in obsessive-compulsive disorder: a comparison with placebo. Arch Gen Psychiatry; 46:36-44.
Goodman,W. K. Price, L. H. Rasmussen, S. A. Mazure, C. Fleischmann, R. L. Hill, C. L. Heninger, G. R. & Charney, D. S. (1989). The Yale–Brown Obsessive Compulsive Scale (Y-BOCS): Part I. Development, use, and reliability. Archives of General Psychiatry, 46, 1006−1011.
Greist, J. Jefferson, J. Koback, K. Katzelnick, D. and Serlin, R. (1995). Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder: A meta-analysis.Archives of General psychiatry, 52,53-60. 165
Higgins, J. P. T. & Thompson, S. G. (2002). Quantifying heterogeneity in a meta-analysis. Statistics in Medicine, 21, 1539−1558.
Huedo-Medina, T. B. Sánchez-Meca, J. Marín-Martínez, F. & Botella, J. (2006). Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychological Methods, 11, 193−206.
Jefferson, J.W. Altemus, M.A. Pigott, T.A. Stien, D.J. and Greist, J.H. (1995). Algorithm for the treatment of obsessive-compulsive disorder (OCD). Psychopharmacology Bulletin,31(3),487-490 156.
Karno, M. Golding, J. J. Sorenson, S. B. & Burnam, M. A. (1988). The epidemiology of obsessive–compulsive disorder in five US communities. Archives of General Psychiatry, 45, 1094−1099.
Keeley, M. L. Storch, E. A. Merlo, L. J. & Geffken, G. R. (2008). Clinical predictors of response to cognitive-behavioral therapy for obsessive–compulsive disorder. Clinical Psychology Review, 28, 118−130.
Kobak, K. A. Greist, J. H. Jefferson, J. W. Katzelnick, D. J. & Henk, H. J. (1998). Behavioral versus pharmacological treatments of obsessive compulsive disorder: A meta-analysis. Psychopharmacology, 136, 205−216.
Lindsay, M. Crino, R. & Andrews, G. (1997). Controlled trial of exposure and response prevention in obsessive-compulsive disorder. British Journal of Psychiatry, 171, 135–139.
Mcdougle, C. j. Gordman, w. k. & Price, L. H. (1993). The pharmaco-therapy of obsessive-compulsive disorder. Pharmopsychiatry. 26: 24-9.
McLean, P. Whittal, M. Thordarson, D. Taylor, S. Soechting, I. Koch, W. et al. (2001). Cognitive versus behavior therapy in the group treatment of Obsessive-Compulsive disorder. Journal of Consulting and Clinical Psychology, 69, 205–214.
Miller, R. C. & Berman, J. S. (1983). The efficacy of cognitive behavior therapies: A quantitative review of the research evidence. Psychological Bulletin, 94(1), 39-53.
Montgomery, S. A. Zohar, Y. (1999). Obsessive-Compulsive Disorder. NewYork: Martin Dunitz Ltd.
Rothstein, H. R. Sutton, A. J. & Borenstein, M. (Eds). (2005). Publication bias in meta-analysis: Prevention, assessment, and adjustments Chichester, UK: Wiley.
Salkovkis, PM. Kirk, I. (1989). Cognitive behavior therapy for psychiatric problems: a practical guide: Oxford University Press.
Sánchez-Meca, J. & Marín-Martínez, F. (2008). Confidence intervals for the overall effect size in random-effects meta-analysis. Psychological Methods, 13, 31−48.
Sánchez-Meca, J. Gómez-Conesa, A. & Méndez, F. X. (2003). El tratamiento psicológico del trastorno obsesivo–compulsivo en Europa: Un estudio meta-analítico [The psychological treatment of obsessive–compulsive disorder in Europe: A meta-analytic study.]. Psicología Conductual, 11, 213−237.
Steketee, G. Henninger, N. & Pollard, C. (2000). Predicting treatment outcome for obsessive-compulsive disorder: Effects of comorbidity. In I. Weiner (Eds). Obsessive-Compulsive disorder: Contemporary issues in treatment (pp. 157–182). New Jersey7 Lawrence Erlbaum Associates.
Storch EA, Merlo LJ. (2006). Obsessive-compulsive disorder: strategies for using CBT and pharmacotherapy. J Fam Pract; 55(4):329-33.
Van Balkom, A. J.L. M. van Oppen, P. Vermeulen, A. W.A.van Dyck, R. Nauta, M. C. E. & Vorst,H.C.M. (1994). A meta-analysis on the treatment of obsessive compulsive disorder: A comparision of antidepressant, behavior, and cognitive therapy. Clinical Psychology Review, 14(5),359-381.
Van Oppen, P. De Haan, E. van Balkom, A. J. Spinhoven, P. Hoogduin, K. A. L. & van Dyck, R. (1995). Cognitive therapy and exposure in vivo in the treatment of obsessive–compulsive disorder. Behavior Research and Therapy, 33, 379−390.
)